Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy

Increased epicardial adipose tissue is associated with left ventricular reverse remodeling in dilated cardiomyopathy

Abstract Background Epicardial adipose tissue (EAT) has been suggested to play paradoxical roles in patients with heart failure. The role of EAT in dilated cardiomyopathy (DCM) patients remains unclear. We aimed to assess the associations between the dynamic changes EAT and left ventricular reverse...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuanwei Xu, Jiajun Guo, Yangjie Li, Shiqian Wang, Ke Wan, Weihao Li, Jie Wang, Ziqian Xu, Wei Cheng, Jiayu Sun, Qing Zhang, Yuchi Han, Yucheng Chen
Format:	Article
Language:	English
Published:	BMC 2024-12-01
Series:	Cardiovascular Diabetology
Subjects:	Dilated cardiomyopathy Cardiac adipose tissue Reverse remodeling Guideline-directed medical therapy
Online Access:	https://doi.org/10.1186/s12933-024-02517-3
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Changes in clinical and imaging variables during withdrawal of heart failure therapy in recovered dilated cardiomyopathy
by: Brian P. Halliday, et al.
Published: (2022-06-01)

Genotype is associated with left ventricular reverse remodelling and early events in recent‐onset dilated cardiomyopathy
by: Milos Kubanek, et al.
Published: (2024-12-01)

Dilated cardiomyopathy and myocarditis: a clinical case
by: O.V. Onyshchenko, et al.
Published: (2023-12-01)

Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts
by: Keiichi Hirono, et al.
Published: (2024-12-01)

Genotype-phenotype insights of pediatric dilated cardiomyopathy
by: Ying Dai, et al.
Published: (2025-01-01)

Outcome and prognostic value of N‐terminal pro‐brain natriuretic peptide and high‐sensitivity C‐reactive protein in mildly dilated cardiomyopathy vs. dilated cardiomyopathy
by: Jiayu Feng, et al.
Published: (2022-06-01)

Correctable Cause of Dilated Cardiomyopathy in an Infant with Heart Failure: ALCAPA Syndrome
by: Osman Güvenç, et al.
Published: (2017-01-01)

Clinical Features and Outcomes of Pediatric MYH7‐Related Dilated Cardiomyopathy
by: Fernando de Frutos, et al.
Published: (2024-11-01)

Layer-Specific Strain Analysis in Patients with Dilated Cardiomyopathy
by: Despina-Manuela Toader, et al.
Published: (2024-12-01)

The change of epicardial adipose tissue characteristics and vulnerability for atrial fibrillation upon drastic weight loss
by: Eva R. Meulendijks, et al.
Published: (2024-12-01)

Dilated cardiomyopathy signature metabolic marker screening: Machine learning and multi-omics analysis
by: Xiao-Lei Li, et al.
Published: (2025-02-01)

Comparing HeartModelAI and cardiac magnetic resonance imaging for left ventricular volume and function evaluation in patients with dilated cardiomyopathy
by: Mahboobeh Sheikh, et al.
Published: (2024-11-01)

Clinical profile of dilated cardiomyopathy in children enrolled in chronic cardiac care: a decade review in a sub-Saharan African tertiary center
by: Henock Gashaw, et al.
Published: (2024-11-01)

Thyroid Storm in the Heart: Graves’ Disease Masquerading as Dilated Cardiomyopathy in an Elderly Male
by: Susheel K. Malani, et al.
Published: (2024-12-01)

The value of D-dimer in the prognosis of dilated cardiomyopathy: a retrospective cohort study
by: Yuan Huang, et al.
Published: (2024-11-01)

Fungal dilated cardiomyopathy in a child with acute lymphoblastic leukemia, what is the optimal agent and duration in therapy?: A case report
by: Aylin Canbolat Ayhan, et al.
Published: (2014-08-01)

Genetic Polymorphism in Peripartum Cardiomyopathy
by: Ivana Purnama Dewi, et al.
Published: (2021-12-01)

BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy
by: Feng Jiang, et al.
Published: (2025-01-01)

Prognostic signature and therapeutic drug identification for dilated cardiomyopathy based on necroptosis via bioinformatics and experimental validation
by: Han Yang, et al.
Published: (2025-01-01)

Association between coronary microvascular dysfunction and exercise capacity in dilated cardiomyopathy
by: Abhishek Dattani, et al.
Published: (2024-01-01)

Intrapericardial injection of hydrogels with ASC and their secretome to treat dilated cardiomyopathies
by: Tácia Tavares Aquinas Liguori, et al.
Published: (2025-01-01)

Adhered macrophages as an additional marker of cardiomyocyte injury in biopsies of patients with dilated cardiomyopathy
by: Warmusz Oliwia, et al.
Published: (2025-02-01)

Association between comorbid COPD or chronic bronchitis and the prognosis of patients with Dilated cardiomyopathy
by: Guiting Zhou, et al.
Published: (2024-12-01)

TAB2 deficiency induces dilated cardiomyopathy by promoting mitochondrial calcium overload in human iPSC-derived cardiomyocytes
by: Wenrui Sun, et al.
Published: (2025-02-01)

Mitral Valve Repair in Pediatric Patients with Dilated Cardiomyopathy and Mitral Insufficiency: Single-Center Experience and Results
by: Mustafa Yılmaz, et al.
Published: (2024-10-01)

Application of the Fifth-Generation Cardiac Contractility Modulation Device in a Patient with Chronic Heart Failure: A Case Report
by: Xie C, et al.
Published: (2024-11-01)

Personalized care in dilated cardiomyopathy: Rationale and study design of the activeDCM trial
by: Farbod Sedaghat‐Hamedani, et al.
Published: (2024-12-01)

Idiopathic Atrial Flutter Associated with Dilated Cardiomyopathy in a Preterm Newborn: A Case Report
by: Nitin Unde, et al.
Published: (2021-07-01)

Criteria of eligibility of patients with ischemic cardiomyopathy for revascularization and other surgical procedures
by: N.D. Oryshchyn
Published: (2016-09-01)

Characterization and natural history of patients with LMNA‐related dilated cardiomyopathy in the phase 3 REALM‐DCM trial
by: Pablo Garcia‐Pavia, et al.
Published: (2024-12-01)

Integrating Circle-Seq with transcriptomics reveals genome-wide characterization of extrachromosomal circular DNA for dilated cardiomyopathy
by: Zhenhao Lin, et al.
Published: (2024-11-01)

A Treatable Cause of Cardiomyopathy: Vitamin D Deficiency
by: Erdal Eren, et al.
Published: (2015-08-01)

Downregulation of miR-214 promotes dilated Cardiomyopathy Progression through PDE5A-Mediated cGMP regulation
by: Jingjing Yan, et al.
Published: (2024-11-01)

The early transition to cold-induced browning in mouse subcutaneous white adipose tissue (scWAT) involves proteins related to nerve remodeling, cytoskeleton, mitochondria, and immune cells
by: Magdalena Blaszkiewicz, et al.
Published: (2024-12-01)

Assessment of myocardial function in Retrievers with dilated cardiomyopathy using 2D speckle tracking echocardiography: a pilot study
by: Lina Hamabe, et al.
Published: (2024-12-01)

Stem cell therapy for non-ischemic dilated cardiomyopathy: a systematic review and meta-analysis
by: Shiyi Tao, et al.
Published: (2024-11-01)

Anesthetic Management of a Patient with Dilated Cardiomyopathy Undergoing Cerebral Aneurysm Clipping Surgery: A Case Report
by: Navneh Samagh, et al.

Utilization of Cardiac Magnetic Resonance Imaging for Assessing Myocardial Fibrosis in Prognosis Evaluation and Risk Stratification of Patients with Dilated Cardiomyopathy
by: Xin-Yi Feng, et al.
Published: (2025-01-01)

Pitavastatin-attenuated cardiac dysfunction in mice with dilated cardiomyopathy via regulation of myocardial calcium handling proteins
by: Hu Wei, et al.
Published: (2014-03-01)

Atrial Cardiomyopathy: From Diagnosis to Treatment
by: Zheyu Liu, et al.
Published: (2025-01-01)